Phase II trials - endpoints, when to randomize

被引：0
|
作者：
Zee, Benny [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2007年 / 2卷 / 08期
关键词：
D O I：
10.1097/01.JTO.0000283066.47583.94
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [21] Monitoring Phase II Comparative Clinical Trials with Two Endpoints and Penalty for Adverse Events
    Bersimis, Sotiris
    Sachlas, Athanasios
    Papaioannou, Takis
    METHODOLOGY AND COMPUTING IN APPLIED PROBABILITY, 2018, 20 (02) : 719 - 738
  • [22] Green tea polyphenols and cancer chemoprevention: Multiple mechanisms and endpoints for phase II trials
    Moyers, SB
    Kumar, NB
    NUTRITION REVIEWS, 2004, 62 (05) : 204 - 211
  • [23] Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer
    Mandrekar, Sumithra J.
    Qi, Yingwei
    Hillman, Shauna L.
    Ziegler, Katie L. Allen
    Reuter, Nicholas F.
    Rowland, Kendrith M., Jr.
    Kuross, Steven A.
    Marks, Randolph S.
    Schild, Steven. E.
    Adjei, Alex A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (01) : 3 - 9
  • [24] A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
    Mozgunov, Pavel
    Jaki, Thomas
    BIOMETRICAL JOURNAL, 2019, 61 (06) : 1477 - 1492
  • [25] Clinical trials for evidence-based radiology: to randomize or not to randomize? This is the question
    Colarieti, Anna
    Sardanelli, Francesco
    RADIOLOGIA MEDICA, 2024, 129 (01): : 80 - 82
  • [26] Clinical trials for evidence-based radiology: to randomize or not to randomize? This is the question
    Anna Colarieti
    Francesco Sardanelli
    La radiologia medica, 2024, 129 : 80 - 82
  • [27] An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints
    Guo, Beibei
    Liu, Suyu
    BIOMETRICAL JOURNAL, 2020, 62 (02) : 339 - 349
  • [28] WHY RANDOMIZE IN CLINICAL-TRIALS
    BARBOSA, J
    CONNETT, J
    RAMSAY, R
    DIABETES CARE, 1983, 6 (01) : 101 - 101
  • [29] Primary Endpoints in Current Phase II/III Trials for Alzheimer Disease A Systematic Survey of Trials Registered at ClinicalTrials.gov
    Takeshima, Nozomi
    Ishiwata, Keita
    Sozu, Takashi
    Furukawa, Toshi A.
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2020, 34 (01): : 97 - 100
  • [30] One-stage and two-stage designs for phase II clinical trials with survival endpoints
    Whitehead, John
    STATISTICS IN MEDICINE, 2014, 33 (22) : 3830 - 3843
12345